CIMO vs DGX
Chimera Investment Corporation (CIMO) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Chimera Investment Corporation (CIMO) common stock listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
CIMO does not have a complete income-statement cache yet.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
CIMO currently screens at market cap $0. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the CIMO and DGX stock pages for the full models.
Not investment advice.